As of Dec 02
| +0.76 / +0.82%|
The 25 analysts offering 12-month price forecasts for Bayer have a median target of 113.78, with a high estimate of 142.50 and a low estimate of 92.42. The median estimate represents a +22.26% increase from the last price of 93.06.
The current consensus among 25 polled investment analysts is to Hold stock in Bayer. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.